Neoplastic mesorectal microfoci (MMF) following neoadjuvant chemoradiotherapy: Clinical and prognostic implications

Annals of Surgical Oncology

Volumn 14, Issue 2, 2007, Pages 853-861

  Ratto, Carlo ^a   Ricci, Riccardo ^a   Valentini, Vincenzo ^a   Castri, Federica ^a   Parello, Angelo ^a   Gambacorta, Maria A ^a   Cellini, Numa ^a   Vecchio, Fabio M ^a   Doglietto, Giovanni B ^a  

^a CATHOLIC UNIVERSITY   (Italy)

Author keywords

Chemoradiation; Local recurrence; Mesorectum; Rectal cancer; Surgery

Indexed keywords

FLUOROURACIL; FOLINIC ACID; MITOMYCIN; RALTITREXED;

ADJUVANT CHEMOTHERAPY; ADULT; ARTICLE; CANCER GRADING; CANCER INCIDENCE; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURGERY; CONTINUOUS INFUSION; FEMALE; HUMAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MULTIPLE CYCLE TREATMENT; NEOPLASTIC MESORECTAL MICROFOCI; PROGNOSIS; RECTUM CANCER; RECTUM TUMOR; TUMOR REGRESSION;

ADENOCARCINOMA; ANTINEOPLASTIC AGENTS; COMBINED MODALITY THERAPY; FEMALE; HUMANS; MALE; MESENTERY; MIDDLE AGED; NEOADJUVANT THERAPY; NEOPLASM STAGING; NEOPLASM, RESIDUAL; PERITONEAL NEOPLASMS; PROGNOSIS; RADIOTHERAPY, ADJUVANT; RECTAL NEOPLASMS; RECTUM; RETROSPECTIVE STUDIES;

EID: 33846595691     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-006-9163-0     Document Type: Article

References (91)

1. Heald RJ, Husband EM, Ryall RD. The mesorectum in rectal cancer surgery - the clue to pelvic recurrence? Br J Surg 1982; 69:613-6.
2. Heald RJ. The 'holy plane' of rectal surgery. J R Soc Med 1988; 81:503-8.
3. MacFarlane JK, Ryall RD, Heald RJ. Mesorectal excision for rectal cancer. Lancet 1993; 341:457-60.
4. Joyce WP, Dolan J, Hyland J. The mesorectum: re-appraisal of its morphology and its unique importance in rectal cancer (abstract). Int J Colorectal Dis 1993; 8:235.
5. Scott N, Jackson P, al-Jaberi T, Dixon MF, Quirke P, Finan PJ. Total mesorectal excision and local recurrence: a study of tumour spread in the mesorectum distal to rectal cancer. Br J Surg 1995; 82:1031-3.
6. Ueno H, Mochizuki H. Clinical significance of extrabowel skipped cancer infiltration in rectal cancer. Surg Today 1997; 27:617-22.
7. Reynolds JV, Joyce WP, Dolan J, Sheahan K, Hyland JM. Pathological evidence in support of total mesorectal excision in the management of rectal cancer. Br J Surg 1996; 83:1112-5.
8. McCall JL. Total mesorectal excision: evaluating the evidence. Aust N Z J Surg 1997; 67:599-602.
9. Hida J, Yasutomi M, Maruyama T, Fujimoto K, Uchida T, Okuno K. Lymph node metastases detected in the mesorectum distal to carcinoma of the rectum by the clearing method: justification of total mesorectal excision. J Am Coll Surg 1997; 184:584-8.
10. Enker WE. Total mesorectal excision-the new golden standard of surgery for rectal cancer. Ann Med 1997; 29:127-33.
11. Heald RJ, Moran BJ, Ryall RD, Sexton R, MacFarlane JK. Rectal cancer: the Basingstoke experience of total mesorectal excision, 1978-1997. Arch Surg 1998; 133:894-9.
12. Leong AF. Selective total mesorectal excision for rectal cancer. Dis Colon Rectum 2000; 43:1237-40.
13. Tocchi A, Mazzoni G, Lepre L, et al. Total mesorectal excision and low rectal anastomosis for the treatment of rectal cancer and prevention of pelvic recurrences. Arch Surg 2001; 136:216-20.
14. Ono C, Yoshinaga K, Enomoto M, Sugihara K. Discontinuous rectal cancer spread in the mesorectum and the optimal distal clearance margin in situ. Dis Colon Rectum 2002; 45:744-9.
15. Heald RJ, Ryall RD. Recurrence and survival after total mesorectal excision for rectal cancer. Lancet 1986; 1:1479-82.
16. Moriya Y, Sugihara K, Akasu T, Fujita S. Patterns of recurrence after nerve-sparing surgery for rectal adenocarcinoma with special reference to loco-regional recurrence. Dis Colon Rectum 1995; 38:1162-8.
17. Enker WE, Thaler HT, Cranor ML, Polyak T. Total mesorectal excision in the operative treatment of carcinoma of the rectum. J Am Coll Surg 1995; 181:335-46.
18. Arbman G, Nilsson E, Hallbook O, Sjodahl R. Local recurrence following total mesorectal excision for rectal cancer. Br J Surg 1996; 83:375-9.
19. Aitken RJ. Mesorectal excision for rectal cancer. Br J Surg 1996; 83:214-6.
20. Merchant NB, Guillem JG, Paty PB, et al. T3N0 rectal cancer: results following sharp mesorectal excision and no adjuvant therapy. J Gastrointest Surg 1999; 3:642-7.
21. GITSG 7175 Prolongation of the disease-free interval in surgically treated rectal carcinoma. Gastrointestinal Tumor Study Group. N Engl J Med 1985; 12:1565-72.
22. Baslev I, Pedersen M, Teglbjaerg PS, et al. Postoperative radiotherapy in Dukes' B and C carcinoma of the rectum and rectosogmoid. Randomized multicenter study. Cancer 1986; 58:22-8.
23. Fisher B, Wolmark N, Rockette H, et al. Postoperative adjuvant chemotherapy or radiation therapy for rectal cancer. Results from NSABP protocol R-01. J Nat Cancer Inst 1988; 80:21-9.
24. Treurniet Donker AD, Van Putten WL, Werwldsma JC. Postoperative radiation therapy for rectal cancer. An interim analysis of a prospective, randomized multicenter trial in the Netherlands. Cancer 1991; 67:2028-42.
25. Krook JE, Moertel CG, Gunderson LL, et al. Effective surgical adjuvant therapy for high risk rectal carcinoma. N Engl J Med 1991; 324:709-15.
26. Bentzen SM, Baslev I, Pederesen M, et al. Time to locoregional recurrence after resection of Dukes' B and C colorectal cancer with or without adjuvant postoperative radiotherapy. A multivariate regression analysis. Br J Cancer 1992; 65:102-7.
27. GISTG 7180. Radiation therapy and fluorouracil with or without semustine for treatment of patients with surgical adjuvant adenocarcinoma of rectum. Gastrointestinal Tumor Study Group. J Clin Oncol 1992; 10:549-57.
28. O'Connel MJ, Martenson JA, Wieand HS, et al. Improving radiation therapy for rectal cancer by combining protracted infusion fluorouracil with radiation therapy after curative surgery. Engl J Med 1994; 331:502-7.
29. Medical Research Council Rectal Cancer Working Party Randomized trial of surgery alone versus surgery followed by radiotherapy for mobile cancer of the rectum. Lancet 1996; 348:1605-10.
30. Arnaud JP, Nordlinger B, Bosset JF, Boes GH, Sahmoud T, Schlag PM, Pene F. Radical surgery and postoperative radiotherapy as combined treatment in rectal cancer. Final results of phase III study of the European Organization for Research and Treatment of Cancer. Br J Surg 1997; 84:352-7.
31. Tveit KM, Guldvog Hagen S E, et al. Randomized controlled trial of postoperative radiotherapy and short-term time-scheduled 5-fluorouracil against surgery alone in the treatment of Dukes' B and C rectal cancer. Br J Surg 1997; 84:1130-5.
32. Wolmark N, Wieand HS, Hyams DM, et al. Randomized trial of postoperative adjuvant chemotherapy with or without radiotherapy for carcinoma of the rectum: National Surgical Adjuvant Breast and Bowel Project Protocol R-02. J Nat Cancer Inst 2000; 92:338-96.
33. Tepper JE, O'Connel M, Niedzwiecki D, et al. Adjuvant therapy in rectal cancer: analysis of stage, sex, and local control. Final report of Intergroup 0114. J Clin Oncol 2002; 20:1774-50.
34. Lee HL, Lee JH, Ahn JH. Randomized trial of postoperative adjuvant therapy in stage II and III rectal cancer to define the optimal sequence of chemotherapy and radiotherapy: a preliminary report. J Clin Oncol 2002; 20:1751-8.
35. Enami B, Pilepich M, Willett C, Munzenrider JE, Miller HH. Effect of preoperative irradiation on resectability of colorectal carcinomas. Int J Radiat Oncol Biol Phys 1982; 8:1335-9.
36. Kapiteijn E, Marijnen CA, Nagtegaal ID, et al. Dutch Colorectal Cancer Group. Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer. N Engl J Med 2001; 34:638-46.
37. Minsky BD, Cohen AM, Kemeny N, et al. Combined modality therapy of rectal cancer. Decreased acute toxicity with the preoperative approach. J Clin Oncol 1992; 10:1218-24.
38. Coco C, Valentini V, Cogliandolo S, Cosimelli MO, Picciocchi A. Surgery and radiotherapy in rectal cancer: indications for anal sphincter conservation. Ann Ital Chir 2001; 72:611-7.
39. Valentini V, Coco C, Cellini N, et al. Ten years of preoperative chemoradiation for extraperitoneal T3 rectal cancer: acute toxicity, tumor response, and sphincter preservation in three consecutive studies. Int J Radiat Oncol Biol Phys 2001; 51:371-83.
40. Onaitis MW, Noone RB, Hartwig M, et al. Neoadjuvant chemoradiation for rectal cancer: analysis of clinical outcomes from a 13-year institutional experience. Ann Surg 2001; 233:778-85.
41. Valentini V, Doglietto GB, Morganti AG, et al. Preoperative chemoradiation with raltitrexed ('Tomudex') for T2/N+ and T3/N+ rectal cancers: a phase I study. Eur J Cancer 2001; 37:2050-5.
42. Kim JS, Kim JS, Cho MJ, Song KS, Yoon WH. Preoperative chemoradiation using oral capecitabine in locally advanced rectal cancer. Int J Radiat Oncol Biol Phys 2002; 54:403-8.
43. Gerard J, Chapet O, Romestaing P, Baulieux J, Hartwig J, Nemoz C. Improved sphincter preservation of low rectal cancer with high dose preoperative radiotherapy: the Lyon R96-02 randomized trial. Int J Radiat Oncol Biol Phys 2003; 57:S179-80.
44. Roedel C, Grabenbauer GG, Hohenberger W, Papadopoulos T, Sauer R. PhaseI/II trial of preoperative chemoradiotherapy with capecitabine and oxaliplatin in locally advanced rectal cancer. Int J Radiat Oncol Biol Phys 2003; 57:S178.
45. Crane CH, Skibber JM, Birnbaum EH, et al. The addition of continuous infusion 5-FU to preoperative radiation therapy increases tumor response, leading to increased sphincter preservation in locally advanced rectal cancer. Int J Radiat Oncol Biol Phys 2003; 57:84-9.
46. Crane CH, Skibber JM, Feig BW, et al. Response to preoperative chemoradiation increases the use of sphincter-preserving surgery in patients with locally advanced low rectal carcinoma. Cancer 2003; 97:517-24.
47. Ciabattoni A, Cavallaro A, Potenza AE, Colli R, Maurizi F, Micciche F, Valentini V. Preoperative concomitant radiochemotherapy with a 5-fluorouracil plus folinic acid bolus in the combined treatment of locally advanced extraperitoneal rectal cancer: a long-term analysis on 27 patients. Tumori 2003; 89:157-63.
48. Luna-Perez P, Rodriguez-Ramirez S, Hernandez-Pacheco F, De Gutierrez La Barrera M, Fernandez R, Labastida S. Anal sphincter preservation in locally advanced low rectal adenocarcinoma after preoperative chemoradiation therapy and coloanal anastomosis. J Surg Oncol 2003; 82:3-9.
49. Pacelli F, Di Giorgio A, Papa V, et al. Preoperative radiotherapy combined with intraoperative radiotherapy improves results of total mesorectal excision in patients with T3 rectal cancer. Dis Colon Rectum 2004; 47:170-9.
50. Gambacorta MA, Valentini V, Morganti AG, et al. Chemoradiation with raltitrexed ("Tomudex") in preoperative treatment of stage II/III resectable rectal cancer: a phase II study. Int J Radiat Oncol Biol Phys 2006 (in press).
51. Chan A, Wong A, Langevin J, Khoo R. Preoperative concurrent 5FU infusion, mitomycin and pelvic radiation therapy in tethered and fixed rectal carcinoma. Int J Radiat Oncol Biol Phys 1993; 25:791-9.
52. Bosset JF, Pavy JJ, Hamers HP, et al. Determination of the optimal dose of 5-fluorouracil when combined with low-dose D.L-Leucovorin and irradiation in rectal cancer: results of 3 consecutive Phase II studies. Eur J Cancer 1993; 33A:1406-10.
53. Rich TA, Skibber JM, Ajani JA, et al. Preoperative infusional chemoradiation therapy for stage T3 rectal cancer. Int J Radiat Oncol Biol Phys 1995; 32:1025-9.
54. Minsky BD, Cohen AM, Enker WE, et al. Preoperative 5FU, low-dose leucovorin and radiation therapy for locally advanced and unresectable rectal cancer. Int J Radiat Oncol Biol Phys 1997; 40:515-22.
55. Graf W, Dahlberg M, Osman MM, Holmberg L, Pahlman L, Glimelius B. Short-term preoperative radiotherapy results in downstaging of rectal cancer: a study of 1316 patients. Rad Oncol 1997; 43:133-7.
56. Morgan MJ, Koorey DJ, Painter D, Findlay M, Tran K, Stevens G, Solomon MJ. Histological tumour response to pre-operative combined modality therapy in locally advanced rectal cancer. Colorectal Dis 2002; 4:177-83.
57. Uzcudun AE, Batlle JF, Velasco JC, et al. Efficacy of preoperative radiation therapy for resectable rectal adenocarcinoma when combined with oral tegafur-uracil modulated with leucovorin: results from a phase II study. Dis Colon Rectum 2002; 45:1349-58.
58. Theodoropoulos G, Wise WE, Padmanabhan A, Kerner BA, Taylor CW, Aguilar PS, Khanduja KS. T-level downstaging and complete pathologic response after preoperative chemoradiation for advanced rectal cancer result in decreased recurrence and improved disease-free survival. Dis Colon Rectum 2002; 45:895-903.
59. Valentini V, Coco C, Picciocchi A, et al. Does downstaging predict improved outcome after preoperative chemoradiation for extraperitoneal locally advanced rectal cancer? A long-term analysis of 165 patients. Int J Radiat Oncol Biol Phys 2002; 53:664-74.
60. Hiotis SP, Weber SM, Cohen AM, et al. Assessing the predictive value of clinical complete response to neoadjuvant therapy for rectal cancer: an analysis of 488 patients. J Am Coll Surg 2002; 194:131-5.
61. Grillo-Ruggieri F, Mantello G, Cardinali M, et al. Downstaging after two different preoperative chemoradiation schedules in rectal cancer. Tumori 2003; 89:164-7.
62. Garcia-Aguilar J, de Hernandez Anda E, Sirivongs P, Lee SH, Madoff RD, Rothenberger DA. A pathologic complete response to preoperative chemoradiation is associated with lower local recurrence and improved survival in rectal cancer patients treated by mesorectal excision. Dis Colon Rectum 2003; 46:298-304.
63. Ota DM, Jacobs L, Kuvshinoff B. Rectal cancer: the sphincter-sparing approach. Surg Clin North Am 2002; 82:983-93.
64. Marks JH, Marchionni C, Marks GJ. Transanal endoscopic microsurgery in the treatment of select rectal cancers or tumors suspicious for cancer. Surg Endosc 2003 May 6 [Epub ahead of print].
65. Kim CJ, Yeatman TJ, Coppola D, et al. Local excision of T2 and T3 rectal cancers after downstaging chemoradiation. Ann Surg 2001; 234:352-8.
66. Singh AK, Myerson RJ, Birnbaum EH, Fleshman JW, Kodner IJ, Lockett MA, Read TE. Outcome of patients with rectal adenocarcinoma and localized pelvic non-nodal metastatic foci. Dis Colon Rectum 2000; 43:1217-21.
67. Ratto C, Ricci R, Rossi C, Morelli U, Vecchio FM, Doglietto GB. Mesorectal microfoci adversely affect the prognosis of patients with rectal cancer. Dis Colon Rectum 2002; 45:733-42.
68. Ono C, Yoshinaga K, Enomoto M, Sugihara K. Discontinuous rectal cancer spread in the mesorectum and the optimal distal clearance margin in situ. Dis Colon Rectum 2002; 45: 744-9.
69. Chan AK, Wong A, Jenken D, Heine J, Johnson D, Buie D. Post-treatment TNM staging is a prognostic indicator of survival and recurrence in tethered or fixed rectal carcinoma after preoperative chemotherapy and radiation. Int J Radiat Oncol Biol Phys 2003; 57:S181.
70. Quirke P, Durdey P, Dixon MF, Williams NS. Local recurrence of rectal adenocarcinoma due to inadequate surgical resection. Histopathological study of lateral tumour spread and surgical excision. Lancet 1986; 2:996-9.
71. Mandard AM, Dalibard F, Mandard JC, et al. Pathologic assessment of Tumor Regression Grade after preoperative chemoradiotherapy of esophageal carcinoma. Cancer 1994; 73:2680-6.
72. Royal College of Surgeons of England, Association of Coloproctology of Great Britain, and Ireland. Guidelines for the management of colorectal cancer. 1996; p25.
73. Camma C, Giunta M, Fiorica F, Pagliaro L, Craxi A, Cottone M. Preoperative radiotherapy for resectable rectal cancer. JAMA 2000; 23:30.
74. Colorectal Cancer Collaborative Group adjuvant radiotherapy for rectal cancer: a systematic overview of 8507 patients from 22 randomized trial. Lancet 2001; 358:1291-304.
75. National Institute of Health Consensus Conference Adjuvant therapy for patients with colon and rectal cancer. JAMA 1990; 264:1444-50.
76. Byfield JE. (1991) Theoretical basis and clinical applications of 5-fluorouracil as a radiosensitizer. An overview. In: Rotman M, Rosenthal CT (eds). Concomitant continuous infusion chemotherapy and radiation Springer, Berlin, Heidelberg, New York, pp 115-27.
77. Lawrence TS, Maybaum J. Fluoropyrimidines as radiation sensitizer. Sem Radiat Oncol 1993; 3:20-8.
78. Ahmad NR, Nagle DA, Topham A. Pathologic complete response predicts long-term survival following preoperative radiation therapy for rectal cancer (abstract). Int J Radiat Oncol Biol Phys 1997; 39:284.
79. Berger C, De Muret A, Garaud P, et al. Preoperative radiotherapy (RT) for rectal cancer: predictive factors of tumor downstaging and residual tumor cell density (RTCD): prognostic implications. Int J Radiat Oncol Biol Phys 1997; 37:619-27.
80. Janjan NA, Khoo VS, Abbruzzese J, et al. Tumor downstaging and sphincter preservation with preoperative chemoradiation in locally advanced rectal cancer: the M. D. Anderson Cancer Center experience. Int J Radiat Oncol Biol Phys 1999; 44:1027-38.
81. Vauthey JN, Marsh R, Zlotecki RA, et al. Recent advances in the treatment and outcome of locally advanced rectal cancer. Ann Surg 1999; 229:745-54.
82. Tjandra JJ, Reading DM, McLachlan SA, et al. Phase II clinical trial of preoperative combined chemoradiation for T3 and T4 resectable rectal cancer: preliminary results. Dis Colon Rectum 2001; 44:1113-22.
83. Sanfilippo NJ, Crane CH, Skibber J, et al. T4 rectal cancer treated with preoperative chemoradiation to the posterior pelvis followed by multivisceral resection: patterns of failure and limitations of treatment. Int J Radiat Oncol Biol Phys 2001; 51:176-83.
84. Garcia-Aguilar J, de Hernandez Anda E, Sirivongs P, Lee SH, Madoff RD, Rothenberger DA. A pathologic complete response to preoperative chemoradiation is associated with lower local recurrence and improved survival in rectal cancer patients treated by mesorectal excision. Dis Colon Rectum 2003; 46:298-304.
85. Read TE, Ogunbiyi OA, Fleshman JW, Birnbaum EH, Fry RD, Myerson RJ, Kodner IJ. Neoadjuvant external beam radiation and proctectomy for adenocarcinoma of the rectum. Dis Colon Rectum 2001; 44:1778-90.
86. Brown CL, Ternent CA, Thorson AG, Christensen MA, Blatchford GJ, Shashidharan M, Haynatzki GR. Response to preoperative chemoradiation in stage II and III rectal cancer. Dis Colon Rectum 2003; 46:1189-93.
87. Luna-Perez P, Rodriguez-Ramirez S, Rodriguez-Coria DF, Fernandez A, Labastida S, Silva A, Lopez MJ. Preoperative chemoradiation therapy and anal sphincter preservation with locally advanced rectal adenocarcinoma. World J Surg 2001; 25:1006-11.
88. Gerard A, Buyse M, Nordlinger B, et al. Preoperative radiotherapy as adjuvant treatment in rectal cancer. Final results of a randomized study of the European Organization for Research and Treatment of Cancer (EORTC). Ann Surg 1988; 208:606.
89. Marsh PJ, James RD, Schofield PF. Adjuvant preoperative radiotherapy for locally advanced rectal carcinoma: results of a prospective randomized trial. Dis Colon Rectum 1994; 37:1205-14.
90. Swedish Rectal Cancer Trial Improved survival with preoperative radiotherapy in resectable rectal cancer. N Engl J Med 1997; 336:980-7.
91. Fleshman JW, Myerson RJ.. Adjuvant radiation therapy for adenocarcinoma of the rectum. Surg Clin North Am 1997; 77:15-25.